Skip to main content
SpringerLink
Log in

Drug-Induced Agranulocytosis

  • Review Article
  • Adverse Drug Experience Review
  • Published:
Medical Toxicology and Adverse Drug Experience Aims and scope Submit manuscript

Summary

Agranulocytosis is a rare but potentially serious adverse side effect of many drugs. Although it was recognised as an idiosyncratic type of drug reaction more than 50 years ago, its pathogenesis is still not fully understood. Drug-related antibodies are responsible for the neutropenia in the so-called ‘immune’ or ‘aminopyrine’ type of agranulocytosis. In contrast to former assumptions, the disappearance of leucocytes is not only due to rapid destruction of circulation cells, but it can result also from failure of the production of granulopoetic cells. In some other groups of drugs there is no evidence of immune-mediated disease, but direct toxicity to bone marrow cells has been observed using biochemical methods or inhibition of the growth of granulopoetic colonies in semisolid culture media. Until now it has not been possible to define the enzymatic abnormality which could explain this metabolic type of idiosyncrasy.

The quantification of the incidence of potentially drug-induced agranulocytosis in general, and in particular its association with single drugs, requires studies on large populations and the use of strict epidemiological methodology to prevent reporting of grossly biased results. Data from recent case control studies show definitely lower risks for some relevant groups of drugs than formerly appreciated. As expected, agranulocytosis has been observed in association with some recently introduced drugs. This underlines the necessity for continued postmarketing monitoring of potential haematological side effects and for further case control studies to furnish data to aid prescribing physicians and health authorities in decision-making.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abt C, Dietrich M, Niethammer D, Arnold R, Pflieger H, et al. Akute arzneimittelinduzierte Agranulocytose Vergleich zwischen herkömmlicher Krankenhausbehandlung und antimikrobieller Dekontamination im Plastikisolierbettsystem. Deutsche Medizinische Wochenschrift 103: 108–114, 1978

    PubMed  CAS  Google Scholar 

  • Allo M, Silva Jr J. Antibiotic agranulocytosis: association with cephalothin and carbenicillin. Southern Medical Journal 70: 1017–1019, 1977

    PubMed  CAS  Google Scholar 

  • Arneborn P, Palmblad J. Drug-induced neutropenia: a survey for Stockholm 1973–1978. Acta Medica Scandinavica 212: 289–292, 1982

    PubMed  CAS  Google Scholar 

  • Ascensao JL, Flynn PJ, Slungaard A, Wachsman W, Zanjani ED, et al. Quinidine-induced neutropenia: report of a case with drug-dependent inhibition of granulocyte colony generation. Acta Haematologica (Basel) 72: 349–354, 1984

    CAS  Google Scholar 

  • Azocar J. Anti-myeloid-cell antibody in procainamide-induced agranulocytosis. Correspondence. Lancet 1: 1069–1070, 1984

    CAS  Google Scholar 

  • Barrett AJ, Weiler E, Rozengurt N, Longhurst P, Humble JG. Amidopyrine agranulocytosis: drug inhibition of granulocyte colonies in the presence of patient’s serum. British Medical Journal 2: 850–851, 1976

    PubMed  CAS  Google Scholar 

  • Benjamin JE, Biederman JB. Agranulocytic leukopenia induced by a drug related to aminopyrine. Journal of the American Medical Association 107: 493–494, 1936

    Google Scholar 

  • Berkman EM, Orlin JB, Wolfsdorf J. An anti-neutrophil antibody associated with a propylthiouracil-induced lupus-like syndrome. Transfusion 23: 135–138, 1983

    PubMed  CAS  Google Scholar 

  • Bilezikian SB, Laleli Y, Tsan MF, Hodkinson BA, Ice S, et al. Immunological reactions involving leukocytes; III: agranulocytosis induced by antithyroid drugs. Johns Hopkins Medical Journal 138: 124–129, 1976

    PubMed  CAS  Google Scholar 

  • Billekop K, Mosbech J. Mortaliteten af agranulocytosis i Danmark i perioden 1958–1972 (Mortality from agranulocytosis in Denmark during the period 1958–1972). Ugeskrift for Laeger 138: 1697–1699, 1976

    PubMed  CAS  Google Scholar 

  • Bock HE, Wiede K. Über Agranulocytose, Aleukie, Ammylhämie und andere Hämozytotoxicosen. Folia Haematologica (Leipzig) 42: 7, 1930

    Google Scholar 

  • Bodenheimer Jr HC, Samarel AM. Agranulocytosis associated with aprindine therapy. Archives of Internal Medicine 139: 1181–1182, 1979

    PubMed  Google Scholar 

  • Boogaerts MA, Peters M, Peersman C, Kesteloot H, Verwilghen R. Mechanisms of aprindine induced agranulocytosis: direct toxicity on CFU-GM and CFU-GEMM. Scandinavian Journal of Haematology 32: 175–178, 1984

    PubMed  CAS  Google Scholar 

  • Brenner LO. Agranulocytosis and ranitidine. Correspondence. Annals of Internal Medicine 104: 896–897, 1986

    CAS  Google Scholar 

  • Böttiger LE, Furhoff AK, Holmberg L. Drug-induced blood dyscrasias: a ten-year material from the Swedish Adverse Drug Reaction Committee. Acta Medica Scandinavica 205: 457–461, 1979

    PubMed  Google Scholar 

  • Böttiger LE, Westerholm B. Drug-induced blood dyscrasias in Sweden. British Medical Journal 3: 339–343, 1973

    PubMed  Google Scholar 

  • Chervenik PA, Zucker-Franklin D, Moore MAS. In vitro and in vivo hematopoiesis. In Zucker-Franklin D et al. (Eds) Atlas of blood cells: function and pathology, Gustav Fischer, Stuttgart, 1986

    Google Scholar 

  • De Gramont A, Canuel C, Krulik M, Bauters F, Degos L, et al. Hematological toxicity of ticlopidine? Nouvelle Revue Française d’Hématologie 24: 35–37, 1982

    PubMed  Google Scholar 

  • De Gruchy GC. Drug-induced blood disorders, pp. 1–204, Blackwell Scientific Publications, Oxford, 1975

    Google Scholar 

  • Discombe G. Agranulocytosis caused by amidopyrine. British Medical Journal I: 1270, 1952

    Google Scholar 

  • Editorial. Antibiotic-induced neutropenia. Lancet 2: 814, 1985

  • Edwards IR. Agranulocytosis and mianserin. Correspondence. New Zealand Medical Journal 98: 75–76, 1985

    CAS  Google Scholar 

  • Eisner EV, Carr RM, MacKinney AR. Quinidine-induced agranulocytosis. Journal of the American Medical Association 238: 884–886, 1977

    PubMed  CAS  Google Scholar 

  • Ellrodt AG, Murata GH, Riedinger MS, Stewart ME, Mochizuki C, et al. Severe neutropenia associated with sustained-release procainamide. Annals of Internal Medicine 100: 197–201, 1984

    PubMed  CAS  Google Scholar 

  • Eriksson KF, Holmberg L, Bergstrand CG. Infectious mononucleosis and agranulocytosis. Scandinavian Journal of Infectious Diseases 11: 307–309, 1979

    PubMed  CAS  Google Scholar 

  • Faich GA. Analgesic risks and pharmacoepidemiology. Editorial. Journal of the American Medical Association 256: 1788, 1986

    CAS  Google Scholar 

  • Fibbe WE, Claas FH, Van der Star-Dijkstra W, Schaafsma MR, Meyboom RH, et al. Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells. British Journal of Haematology 64: 363–373, 1986

    PubMed  CAS  Google Scholar 

  • Friman G, Nyström-Rosander C, Jonsell G, Björkman A, Lekas A, et al. Agranulocytosis associated with malaria prophylaxis with Maloprim. British Medical Journal 286: 1244–1245, 1983

    PubMed  CAS  Google Scholar 

  • Goudemand J, Plouvier J, Bauters F, Goudemand M. Les agranulocytoses induites par le pyramidon ou les phenothiazines a propos de 31 observations. Semaine des Hôpitaux 52: 1513–1520, 1976

    PubMed  CAS  Google Scholar 

  • Gross R, Horstmann H, Vogel J, Zach J. Zur Epidemiologie und Klinik der medikamentös-allergischen Agranulozytose. Medizinische Welt 31: 1767–1779, 1967

    PubMed  CAS  Google Scholar 

  • Guffy MM, Goeken NE, Burns CP. Granulocytotoxic antibodies in a patient with propylthiouracil-induced agranulocytosis. Archives of Internal Medicine 144: 1687–1688, 1984

    PubMed  CAS  Google Scholar 

  • Hartl W. Drug allergic agranulocytosis (Schultz’s disease). Seminars in Hematology 2: 313–337, 1965

    PubMed  CAS  Google Scholar 

  • Hartl W. Drug induced agranulocytosis. In Girdwood RH (Ed.) Blood disorders due to drugs and other agents, pp. 147–186, Excerpta Medica, Amsterdam, 1973

    Google Scholar 

  • Hatton CS, Peto TE, Bunch C, Pasvol G, Russell SJ, et al. Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet 1: 411–414, 1986

    PubMed  CAS  Google Scholar 

  • Hauswaldt C, Hunstein W, Perings E. Amidopyrin-Agranulocytose mit gleichzeitiger Erythroblastopenie. Deutsche Medizinische Wochenschrift 91: 1832–1836, 1966

    PubMed  CAS  Google Scholar 

  • Heimpel H, Abt C. Medikamente und akute Agranulozytose. Deutsche Medizinische Wochenschrift 104: 731–736, 1979

    PubMed  CAS  Google Scholar 

  • Heit W, Heimpel H, Fischer A, Frickhofen N. Drug-induced agranulocytosis: evidence for the commitment of bone marrow haematopoiesis. Scandinavian Journal of Haematology 35: 459–468, 1985

    PubMed  CAS  Google Scholar 

  • Hennemann HH, Schief A. Rezidive von Argranulozytose. Deutsche Medizinische Wochenschrift 100: 519–520, 1975

    PubMed  CAS  Google Scholar 

  • Hodinka L, Geher P, Meretey K, Gyodi EK, Petranyi GG, et al. Levamisole-induced neutropenia and agranulocytosis: association with HLA B27 and demonstration of leukocyte agglutinating and lymphocytotoxic antibodies. International Archives of Allergy and Applied Immunology 460–464, 1981

  • Honegger HP, Graf M, von Feiten A, Lammli J, Imbach P, et al. Drug induced agranulocytosis: improved prognosis due to better supportive care. Schweizerische Medizinische Wochenschrift 108: 1182–1189, 1978

    PubMed  CAS  Google Scholar 

  • Homer W, Ehninger G, Gaertner HJ. Perazine-induced agranulocytosis: case report and discussion. Psychiatrische Praxis 12: 23–24, 1985

    Google Scholar 

  • Huguley CM. Agranulocytosis induced by dipyrone, a hazardous antipyretic and analgesic. Journal of the American Medical Association 189: 938–941, 1964

    PubMed  CAS  Google Scholar 

  • Huguley CM, Lea JW, Butis JA. Adverse hematologic reactions to drugs. Progress in Hematology 5: 105–136, 1966

    PubMed  CAS  Google Scholar 

  • Idänpään Heikkilä J, Alhava E, Olkinuora M, Palva IP. Agranulocytosis during treatment with clozapine. European Journal of Clinical Pharmacology 11: 193–198, 1977

    PubMed  Google Scholar 

  • International Agranulocytosis and Aplastic Anemia Study (IAAAS). The design of a study of the drug etiology of agranulocytosis and aplastic anemia. European Journal of Clinical Pharmacology 24: 833–836, 1983

    Google Scholar 

  • International Agranulocytosis and Aplastic Anemia Study (IAAAS). Risks of agranulocytosis and aplastic anemia: a first report of their relation to drug use with special reference to analgesics. Journal of the American Medical Association 256: 1749–1757, 1986

    Google Scholar 

  • International Agranulocytosis and Aplastic Anemia Study (IAAAS). Risk of agranulocytosis and aplastic anemia in relation to antithyroid drug use. British Medical Journal, in press, 1988

  • Irvine AE, Morris TC, Kelly GJ, McCracken N. Ticarcillin-induced neutropenia corroborated by in vitro CFU-C toxicity. Acta Haematologica (Basel) 70: 364–368, 1983

    CAS  Google Scholar 

  • Kantero I, Mustala OO, Palva IP. Drug-induced agranulocytosis, with special reference to aminophenazone, IV: children. Acta Medica Scandinavica 192: 327–330, 1972

    PubMed  CAS  Google Scholar 

  • Karch FE, Lasagna L. Adverse drug reactions: a critical review. Journal of the American Medical Association 234: 1236–1241, 1975

    PubMed  CAS  Google Scholar 

  • Kelton JG, Huang AT, Mold N, Logue G, Rosse WF. The use of in vitro techniques to study drug-induced pancytopenia. New England Journal of Medicine 301: 621–659, 1979

    PubMed  CAS  Google Scholar 

  • Kirkwood CF, Lasezkay GM. Neutropenia associated with mezlocillin and piperacillin. Drug Intelligence and Clinical Pharmacy 19: 112–114, 1985

    PubMed  CAS  Google Scholar 

  • Korst DR. Agranulocytosis caused by phenothiazine derivates. Journal of the American Medical Association 170: 2076, 1959

    PubMed  CAS  Google Scholar 

  • Koziner B, Hadler N, Parrillo J, Ellman L. Agranulocytosis following infectious mononucleosis. Journal of the American Medical Association 225: 1235–1236, 1973

    PubMed  CAS  Google Scholar 

  • Kracke R. Recurrent agranulocytosis, report of an unusual case. American Journal of Clinical Pathology 1: 385–390, 1931

    Google Scholar 

  • Kramer MS, Lane DA, Hutchinson TA. Analgesic use, blood dyscrasia and case control pharmacoepidemiology. Journal of Chronic Diseases 40: 1073–1081, 1987

    PubMed  CAS  Google Scholar 

  • Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR. An algorithm for the operational assessment of adverse drug reactions: background, description, and instructions for use. Journal of the American Medical Association 242: 623–632, 1979

    PubMed  CAS  Google Scholar 

  • Lawson AA, McArdle T, Ghosh S. Cephradine-associated immune neutropenia. Correspondence. New England Journal of Medicine 312: 651, 1985

    CAS  Google Scholar 

  • Leen C, Gibb AP, Brettle RP, Welsby PD. Transient neutropenia and thrombocytopenia due to benoxaprofen. Correspondence. Lancet 1: 1302, 1982

    CAS  Google Scholar 

  • Levin MH, Weinstein RA, Axelrod JL, Schantz PM. Severe, reversible neutropenia during high-dose mebendazole therapy for echinococcosis. Journal of the American Medical Association 249: 2929–2931, 1983

    PubMed  CAS  Google Scholar 

  • Lomas J. Chlorpromazine and agranulocytosis. British Medical Journal 2: 358, 1954

    Google Scholar 

  • Luther AL, Wade JS, Slaughter JM. Agranulocytosis secondary to methimazole therapy: report of two cases. Southern Medical Journal 69: 1356–1357, 1976

    PubMed  CAS  Google Scholar 

  • Madison FW, Squier TL. The etiology of primary granulocytopenia (agranulocytic angina). Journal of the American Medical Association 102: 755–759, 1934

    Google Scholar 

  • Magis CC, Barge A, Dausset J. Serological study of an allergic agranulocytosis due to noramidopyrine. Clinical and Experimental Immunology 3: 989–1003, 1968

    PubMed  CAS  Google Scholar 

  • Mandel A, Gross M. Agranulocytosis and phenothiazines. Diseases of the Nervous System 29: 32–36, 1968

    PubMed  CAS  Google Scholar 

  • Mayrhofer EF, Davogg S, Feilhauer GD, Pilecky I, Seisenbacher H, et al. Fallbericht einer schweren, möglicherweise propafenonverursachten Granulocytopenie. Wiener Medizinische Wochenschrift 132: 273–275, 1982

    PubMed  CAS  Google Scholar 

  • McEwen J, Strickland WJ. Mebhydrolin napadisylate: a possible cause of reversible agranulocytosis and neutropenia. Medical Journal of Australia 2: 523–525, 1982

    PubMed  CAS  Google Scholar 

  • Meyers DG, Gonzalez ER, Peters LL, Davis RB, Feagler JR, et al. Severe neutropenia associated with procainamide: comparison of sustained release and conventional preparations. American Heart Journal 109: 1393–1395, 1985

    PubMed  CAS  Google Scholar 

  • Moeschlin S. Immunological granulocytopenia and agranulocytosis. Sang 26: 32–51, 1955

    PubMed  CAS  Google Scholar 

  • Moeschlin S, Moreno R. Pyramidon-Agranulozytose mit Agglutininen für arteigene und artfremde Leukocyten. Klinische Wochenschrift 33: 799–802, 1954

    Google Scholar 

  • Moeschlin S, Wagner K. Agranulocytosis due to the occurrence of leukocyte-agglutinins. Acta Haematologica (Basel) 8: 29–41, 1952

    CAS  Google Scholar 

  • Murphy MF, Riordan T, Minchinton RM, Chapman JF, Amess JA, et al. Demonstration of an immune-mediated mechanism of penicillin-induced neutropenia and thrombocytopenia. British Journal of Haematology 55: 155–160, 1983

    PubMed  CAS  Google Scholar 

  • Nagaraju M, Weitzman S, Baumann G. Viral hepatitis and agranulocytosis. American Journal of Digestive Diseases 18: 247–252, 1973

    PubMed  CAS  Google Scholar 

  • Neel EU. Infectious mononucleosis: death due to agranulocytosis and pneumonia. Journal of the American Medical Association 236: 1493–1494, 1976

    PubMed  CAS  Google Scholar 

  • Neftel KA, Hauser SP, Muller MR. Inhibition of granulopoiesis in vivo and in vitro by beta-lactam antibiotics. Journal of Infectious Diseases 152: 90–98, 1985

    PubMed  CAS  Google Scholar 

  • Nygard N, Starkebaum G. Naproxen and agranulocytosis. Correspondence. Journal of the American Medical Association 257: 1732, 1987

    CAS  Google Scholar 

  • Olsen KM, Thompson GD, Sullivan MD. Possible agranulocytosis secondary to zomepirac. Clinical Pharmacy 3: 85–87, 1984

    PubMed  CAS  Google Scholar 

  • Page CE. Mianserin-induced agranulocytosis. British Medical Journal 284: 1912–1913, 1982

    PubMed  CAS  Google Scholar 

  • Palva IP, Mustala OO. Drug-induced agranulocytosis, with special reference to aminophenazone, I: adults. Acta Medica Scandinavica 187: 109–115, 1970

    PubMed  CAS  Google Scholar 

  • Palva IP, Mustala OO. Drug-induced agranulocytosis, II: the role of medication in a fatal outcome. Acta Medica Scandinavica 191: 121–124, 1972

    PubMed  CAS  Google Scholar 

  • Petz LD, Fundenberg HH. Immunologic mechanisms in drug-induced cytopenias. Progress in Hematology 9: 185–206, 1975

    PubMed  CAS  Google Scholar 

  • Pisciotta AV. Studies on agranulocytosis, VII: limited proliferative potential of chlorpromazine-sensitive patients. Journal of Laboratory and Clinical Medicine 65: 240, 1965

    PubMed  CAS  Google Scholar 

  • Pisciotta AV. Immune and toxic mechanisms in drug induced cytopenias. Seminars in Hematology 10: 279–310, 1973

    PubMed  CAS  Google Scholar 

  • Pisciotta AV, Cronkite C. Aprindine-induced agranulocytosis: evidence for immunologic mechanism. Archives of Internal Medicine 143: 241–243, 1983

    PubMed  CAS  Google Scholar 

  • Pisciotta V. Drug-induced agranulocytosis. Drugs 15: 132–143,1978

    PubMed  CAS  Google Scholar 

  • Price TH, Dale DC. The selective neutropenias. Clinics in Haematology 7: 501–521, 1978

    PubMed  CAS  Google Scholar 

  • Ream RS, Kerr RO. Neutropenia associated with maprotiline. Journal of the American Medical Association 248: 871, 1982

    PubMed  CAS  Google Scholar 

  • Rosenthal M. Granulocytotoxic antibodies in levamisole-induced agranulocytosis. Klinische Wochenschrift 60: 1297–1302, 1982

    PubMed  CAS  Google Scholar 

  • Rosove MH. Agranulocytosis and antithyroid drugs. Western Journal of Medicine 126: 339–343, 1977

    PubMed  CAS  Google Scholar 

  • Rouveix B, Lassoued K, Vittecoq D, Regnier B. Neutropenia due to beta lactamine antibodies. British Medical Journal 287: 1832–1834, 1983

    PubMed  CAS  Google Scholar 

  • Ruvidic R, Jelic S. Haematological aspects of drug-induced agranulocytosis. Scandinavian Journal of Haematology 9: 18–27, 1972

    PubMed  CAS  Google Scholar 

  • Schlesselman JJ. Case-control studies, New York, Oxford. Oxford University Press, Oxford, 1982

    Google Scholar 

  • Schmid L, Heit W, Flury R. Agranulocytosis associated with semisynthetic penicillins and cephalosporins: report of 7 cases. Blut 48: 11–18, 1984

    PubMed  CAS  Google Scholar 

  • Schultz W. Über eigenartige Halserkrankungen. Deutsche Medizinische Wochenschrift 48: 1495, 1922

    Google Scholar 

  • Sedlacek SM, Rudolf PM, Kaehny WD. Amoxapine-associated agranulocytosis with thrombocytosis occurring early during recovery. American Journal of Medicine 80: 533–536, 1986

    PubMed  CAS  Google Scholar 

  • Soff GA, Kadin ME. Tocainide-induced reversible agranulocytosis and anemia. Correspondence. American Journal of Medicine 82: 576–578, 1987

    Google Scholar 

  • Stanley ER, Jubinsky PT. Factors affecting the growth and differentiation of hemopoetic cells in culture. Clinics in Haematology 13: 329–348, 1984

    PubMed  CAS  Google Scholar 

  • Sutherland R, Vincent PC, Raik E, Burgess K. Quinine-induced agranulocytosis: toxic effect of quinine bisulphate on bone marrow cultures in vitro. British Medical Journal 1: 605–607, 1977

    PubMed  CAS  Google Scholar 

  • Symoens J, Veys E, Mielants M, Pinals R. Adverse reactions to levamisole. Cancer Treatment Reports 62: 1721–1730, 1978

    PubMed  CAS  Google Scholar 

  • Symon DN, Russell G. Sodium valproate and neutropenia. Correspondence. Archives of Disease in Children 58: 235, 1983

    CAS  Google Scholar 

  • Taetle R, Lane TA, Mendelsohn J. Drug-induced agranulocytosis: in vitro evidence for immune suppression of granulopoiesis and a cross-reacting lymphocyte antibody. Blood 54: 501–511, 1979

    PubMed  CAS  Google Scholar 

  • Thierfelder S, Eulitz M, Karl ML. Immunologische Studien an einem Pyramidon-Leukozytenantikörper. Klinische Wochenschrift 45: 78–83, 1967

    PubMed  CAS  Google Scholar 

  • Thierfelder S, Magis C, Saint-Paul M, Dausset J. Die Pyramidon-Agranulocytose. Deutsche Medizinische Wochenschrift 11: 506–512, 1964

    Google Scholar 

  • Valiaveedan R, Rao S, Miller S, Brown A. Transient neutropenia of childhood. Clinical Pediatrics 26: 639–642, 1987

    PubMed  CAS  Google Scholar 

  • Vande Stouwe RA, Attia AA, Kranas A, Ciavarella D, Grieco MH. Transient agranulocytosis associated with non-A, non-B hepatitis. Gastroenterology 85: 186–189, 1983

    Google Scholar 

  • Varonos DD, Santamouris S, Karambali S. The incidence of dipyrone-induced agranulocytosis in Greece during 1975. Journal of International Medical Research 7: 564–568, 1979

    PubMed  CAS  Google Scholar 

  • Vincent PC. Drug-induced aplastic anemia and agranulocytosis: incidence and mechanisms. Drugs 31: 52–63, 1986

    PubMed  CAS  Google Scholar 

  • Vogel CL, Silverman MA, Mansell PW, et al. Mechanism of levamisol-induced granulocytopenia in breast cancer patients. American Journal of Hematology 9: 171–183, 1980

    PubMed  CAS  Google Scholar 

  • Voth AJ, Turner RH. Nifedipine and agranulocytosis. Correspondence. Annals of Internal Medicine 99: 882, 1983

    CAS  Google Scholar 

  • Weetman RM, Boxer LA. Childhood neutropenia. Pediatric Clinics of North America 27: 361–376, 1980

    PubMed  CAS  Google Scholar 

  • Weitzman SA, Stossel TP. Drug-induced immunological neutropenia. Lancet 1: 1068–1072, 1978

    PubMed  CAS  Google Scholar 

  • Wiberg JJ, Nuttall FQ. Methimazole toxicity from high doses. Annals of Internal Medicine 77: 414–416, 1972

    PubMed  CAS  Google Scholar 

  • Williams GT, Johnson SA, Dieppe PA, Huskisson EC. Neutropenia during treatment of rheumatoid arthritis with levamisole. Annals of the Rheumatic Diseases 37: 366–369, 1978

    PubMed  CAS  Google Scholar 

  • Young GA, Forrest P, Deveridge SF, Gates RB, Vincent PC. Mebhydrolin induced agranulocytosis. Australian and New Zealand Journal of Medicine 12: 173–176, 1982

    PubMed  CAS  Google Scholar 

  • Young GAR, Vincent PC. Drug-induced agranulocytosis. Clinics in Haematology 9: 483–504, 1980

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Innere Medizin III, Medizinische Klinik und Poliklinik der Universität Ulm, Postfach 3880, Steinhövstrasse 9, D-7900, Ulm, West Germany

    Hermann Heimpel

Authors
  1. Hermann Heimpel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Heimpel, H. Drug-Induced Agranulocytosis. Med Toxicol Adverse Drug Exp 3, 449–462 (1988). https://doi.org/10.1007/BF03259896

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03259896

Keywords

Search

Navigation